UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 271

Sortiert nach

Effects of a higher dose of alglucosidase alfa on ventilator-free survival and motor outcome in classic infantile Pompe disease: an open-label single-center study

Journal of inherited metabolic disease, 2016-05, Vol.39 (3), p.383-390

2016

Link zum Volltext

Verfügbarkeit prüfen

Childhood Pompe disease: clinical spectrum and genotype in 31 patients

Orphanet journal of rare diseases, 2016-05, Vol.11 (1), p.65-65, Article 65

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients

Brain (London, England : 1878), 2005-03, Vol.128 (3), p.671-677

2005

Link zum Volltext

Verfügbarkeit prüfen

Broad spectrum of Pompe disease in patients with the same c.-32-13T->G haplotype

Neurology, 2007-01, Vol.68 (2), p.110

2007

Link zum Volltext

Verfügbarkeit prüfen

The natural course of non-classic Pompe's disease; a review of 225 published cases

Journal of neurology, 2005-08, Vol.252 (8), p.875-884

2005

Link zum Volltext

Verfügbarkeit prüfen

Muscle fiber-type distribution, fiber-type-specific damage, and the Pompe disease phenotype

Journal of inherited metabolic disease, 2013-09, Vol.36 (5), p.787-794

2013

Link zum Volltext

Verfügbarkeit prüfen

Cardiac evaluation in children and adults with Pompe disease sharing the common c.−32-13T>G genotype rarely reveals abnormalities

Journal of the neurological sciences, 2008-12, Vol.275 (1), p.46-50

2008

Link zum Volltext

Verfügbarkeit prüfen

Enzyme therapy for Pompe disease with recombinant human α‐glucosidase from rabbit milk

Journal of inherited metabolic disease, 2001-04, Vol.24 (2), p.266-274

2001

Link zum Volltext

Verfügbarkeit prüfen

Enzyme analysis for Pompe disease in leukocytes; superior results with natural substrate compared with artificial substrates

Journal of inherited metabolic disease, 2009-06, Vol.32 (3), p.416-423

2009

Link zum Volltext

Verfügbarkeit prüfen

Bone, joint and tooth development in mucopolysaccharidoses: Relevance to therapeutic options

Biochimica et biophysica acta, 2011-11, Vol.1812 (11), p.1542-1556

2011

Link zum Volltext

Verfügbarkeit prüfen

Rate of progression and predictive factors for pulmonary outcome in children and adults with Pompe disease

Molecular genetics and metabolism, 2011-09, Vol.104 (1-2), p.129-136

2011

Link zum Volltext

Verfügbarkeit prüfen

Rate of disease progression during long-term follow-up of patients with late-onset Pompe disease

Neuromuscular disorders : NMD, 2009-02, Vol.19 (2), p.113-117

2009

Link zum Volltext

Verfügbarkeit prüfen

Inconsistent reporting about dosing, dosing regimen, and immunomodulation therapy in Pompe disease

Genetics in medicine, 2012-09, Vol.14 (9), p.827; author reply 827-828

Reuser, A J J

2012

Link zum Volltext

Verfügbarkeit prüfen

Disease severity in children and adults with Pompe disease related to age and disease duration

Neurology, 2005-06, Vol.64 (12), p.2139

2005

Link zum Volltext

Verfügbarkeit prüfen

Generalized glycogen storage and cardiomegaly in a knockout mouse model of Pompe disease

Human molecular genetics, 1998, Vol.7 (1), p.53-62

1998

Link zum Volltext

Verfügbarkeit prüfen

Recombinant human α-glucosidase from rabbit milk in Pompe patients

The Lancet (British edition), 2000-07, Vol.356 (9227), p.397-398

2000

Link zum Volltext

Verfügbarkeit prüfen

Enzyme therapy in Pompe disease: questions remain

Molecular genetics and metabolism, 2012-09, Vol.107 (1-2), p.243-243

Reuser, A.J.J.

2012

Link zum Volltext

Verfügbarkeit prüfen

Eight years experience with enzyme replacement therapy in two children and one adult with Pompe disease

Neuromuscular disorders : NMD, 2008-06, Vol.18 (6), p.447-452

2008

Link zum Volltext

Verfügbarkeit prüfen

Fatigue : an important feature of late-onset Pompe disease

Journal of neurology, 2007-07, Vol.254 (7), p.941-945, Article 941

2007

Link zum Volltext

Verfügbarkeit prüfen

Effect of enzyme therapy in juvenile patients with Pompe disease: A three-year open-label study

Neuromuscular disorders : NMD, 2010-12, Vol.20 (12), p.775-782

2010

Link zum Volltext

Verfügbarkeit prüfen

Course of disability and respiratory function in untreated late-onset Pompe disease

Neurology, 2006-02, Vol.66 (4), p.581

2006

Link zum Volltext

Verfügbarkeit prüfen

Hemoglobin precipitation greatly improves 4-methylumbelliferone-based diagnostic assays for lysosomal storage diseases in dried blood spots

Molecular genetics and metabolism, 2011, Vol.102 (1), p.44-48

2011

Link zum Volltext

Verfügbarkeit prüfen

Novel GAA sequence variant c.1211 A>G reduces enzyme activity but not protein expression in infantile and adult onset Pompe disease

Gene, 2014-03, Vol.537 (1), p.41-45

2014

Link zum Volltext

Verfügbarkeit prüfen

Late-onset Pompe disease primarily affects quality of life in physical health domains

Neurology, 2004-11, Vol.63 (9), p.1688

2004

Link zum Volltext

Verfügbarkeit prüfen

Structural and functional changes of lysosomal acid alpha-glucosidase during intracellular transport and maturation

The Journal of biological chemistry, 1993-01, Vol.268 (3), p.2223-2231

1993

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 271

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(260)
Mit Volltextzugriff
(233)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(199)
Humans
(197)
Life Sciences & Biomedicine
(195)
Biological And Medical Sciences
(92)
Male
(90)
Female
(82)
Genetics & Heredity
(75)
Medical Sciences
(69)
Animals
(61)
Adult
(57)
Glycogen Storage Disease Type Ii - Genetics
(52)
Alpha-Glucosidases - Genetics
(48)
Glycogen Storage Disease Type Ii - Enzymology
(46)
Metabolic Diseases
(46)
Biochemistry & Molecular Biology
(43)
Errors Of Metabolism
(43)
Infant
(40)
Mutation
(37)
Medicine, Research & Experimental
(36)
Carbohydrates . Glycogenosis
(35)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effects of a higher dose of alglucosidase alfa on ventilator-free survival and motor outcome in classic infantile Pompe disease: an open-label single-center study

Childhood Pompe disease: clinical spectrum and genotype in 31 patients

Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients

Broad spectrum of Pompe disease in patients with the same c.-32-13T->G haplotype

The natural course of non-classic Pompe's disease; a review of 225 published cases

Muscle fiber-type distribution, fiber-type-specific damage, and the Pompe disease phenotype

Cardiac evaluation in children and adults with Pompe disease sharing the common c.−32-13T>G genotype rarely reveals abnormalities

Enzyme therapy for Pompe disease with recombinant human α‐glucosidase from rabbit milk

Enzyme analysis for Pompe disease in leukocytes; superior results with natural substrate compared with artificial substrates

Bone, joint and tooth development in mucopolysaccharidoses: Relevance to therapeutic options

Rate of progression and predictive factors for pulmonary outcome in children and adults with Pompe disease

Rate of disease progression during long-term follow-up of patients with late-onset Pompe disease

Inconsistent reporting about dosing, dosing regimen, and immunomodulation therapy in Pompe disease

Disease severity in children and adults with Pompe disease related to age and disease duration

Generalized glycogen storage and cardiomegaly in a knockout mouse model of Pompe disease

Recombinant human α-glucosidase from rabbit milk in Pompe patients

Enzyme therapy in Pompe disease: questions remain

Eight years experience with enzyme replacement therapy in two children and one adult with Pompe disease

Fatigue : an important feature of late-onset Pompe disease

Effect of enzyme therapy in juvenile patients with Pompe disease: A three-year open-label study

Course of disability and respiratory function in untreated late-onset Pompe disease

Hemoglobin precipitation greatly improves 4-methylumbelliferone-based diagnostic assays for lysosomal storage diseases in dried blood spots

Novel GAA sequence variant c.1211 A>G reduces enzyme activity but not protein expression in infantile and adult onset Pompe disease

Late-onset Pompe disease primarily affects quality of life in physical health domains

Structural and functional changes of lysosomal acid alpha-glucosidase during intracellular transport and maturation

Suchergebnisse filtern